Instituto del Corazon
Bucaramanga, Colombia
Cardiologist in Bucaramanga
Cra. 28 ## 40-11, Bucaramanga, Santander
About Instituto del Corazon
"Servicios de cardiología para pacientes adultos y pediátricos"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Amaranth Medical Inc.
3
Bayer
2
Pfizer
2
Abbott Medical Devices
1
Newron Pharmaceuticals SPA
1
Unity Health Toronto
1
Clinical Trials at Instituto del Corazon
During the past decade, Instituto del Corazon conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist
2007-11-01
2012-03-01
Completed
679
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
Feasibility Study of the Amaranth Medical FORTITUDE Bioresorbable Drug-Eluting Coronary Stent
2014-09-01
2020-11-01
Unknown status
42
Safety and Efficacy Study of the Amaranth Medical APTITUDE Bioresorbable Drug-Eluting Coronary Stent
2015-11-01
2021-07-01
Unknown status
60
Safety and Efficacy Study of the Amaranth Medical MAGNITUDE Bioresorbable Drug-Eluting Coronary Stent (RENASCENT III)
2016-10-01
2022-06-01
Unknown status
70
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Instituto del Corazon" #1 sponsor was "Amaranth Medical Inc." with 3 trials, followed by "Bayer" with 2 trials
sponsored, "Pfizer" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "Newron Pharmaceuticals SPA"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
Clinical Trials Conditions at Instituto del Corazon
According to Clinical.Site data, the most researched conditions in "Instituto del Corazon" are
"Coronary Artery Disease" (3 trials), "Myocardial Ischemia" (3 trials), "Cardiovascular Disease" (2 trials), "Atrial Fibrillation" (1 trials) and "Disorder; Heart, Functional, Postoperative, Cardiac Surgery" (1 trials). Many other conditions were trialed in "Instituto del Corazon" in a lesser frequency.
Clinical Trials Intervention Types at Instituto del Corazon
Most popular intervention types in "Instituto del Corazon" are "Drug" (5 trials), "Device" (4 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "bococizumab (PF-04950615)" (2 trials), "AmM APTITUDE Bioresorbable Drug-Eluting Coronary Scaffold" (1 trials), "AmM FORTITUDE Bioresorbable Drug-Eluting Coronary Scaffold" (1 trials) and "AmM MAGNITUDE Bioresorbable Drug-Eluting Coronary Scaffold" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Instituto del Corazon
The vast majority of trials in "Instituto del Corazon" are
10 trials for "All" genders.
Clinical Trials Status at Instituto del Corazon
Currently, there are NaN active trials in "Instituto del Corazon".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Instituto del Corazon,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Instituto del Corazon, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".